YONGTAI TECH.(SZ:002326)2022-12-03 08:34Group 1: Company Overview - The company focuses on fluorine fine chemicals, extending its business into pharmaceuticals, pesticides, and electronic chemicals, establishing a vertically integrated industrial chain from intermediates to APIs and formulations [1] - The company provides high-quality products and services to domestic and foreign clients [1] Group 2: Core Competencies - The company adheres to a growth strategy of "internal growth and external expansion," leveraging its fluorination technology, chiral enzyme catalysis, and green reaction technologies to extend its pharmaceutical and pesticide chains into high-value downstream areas [2] - The majority of the company's product varieties can be sold independently, demonstrating strong market adaptability and significant potential for product structure adjustment [2] - The company utilizes a production model that allows for the comprehensive use of by-products, reducing overall production costs [2] Group 3: Future Growth Points - Traditional products are expected to grow steadily, with multiple projects underway, including the Inner Mongolia Yongtai project and the Yongtai hand-in project, which are progressing smoothly [3] - The newly established pharmaceutical formulation production base has entered the commercial production phase, and the initial capacity of lithium battery materials is gradually being released, which will be key profit growth points over the next three years [3] Group 4: Development Strategy - The company aims to enhance existing production facilities, improve management levels, R&D capabilities, and environmental standards, while intensifying market development efforts, especially in deepening relationships with key customers [3] - The company plans to leverage its capital market advantages to achieve both internal growth and external development [3] Group 5: Pharmaceutical Sector Insights - The pharmaceutical sector is currently the highest revenue-generating segment and a key focus for future development, with plans to diversify into cardiovascular, diabetes, and antiviral fields [4] - The company aims to establish high-tech barriers in the formulation sector, promoting the development of a vertically integrated platform [4] Group 6: Technical Advantages - The company has developed a vertically integrated industrial chain from intermediates to formulations based on its unique fluorination technology and proprietary biocatalysis technology [5] - The company possesses advanced chiral enzyme catalysis technologies, significantly improving production efficiency and reducing costs [5] Group 7: Project Progress - The Inner Mongolia Yongtai project is expected to produce 18,715 tons of fine chemicals and 30,000 tons of potassium fluoride annually, with construction progressing smoothly since March 2020 [6] - The Yongtai hand-in project is currently preparing for trial production [5] Group 8: Market Outlook - The price increase of lithium hexafluorophosphate is expected to enhance the economic benefits of the electronic chemicals segment, as the company has improved production processes and cost control [6] - The dual fluorosulfonyl lithium product has a promising market outlook due to its high thermal stability and conductivity, despite currently being primarily imported [7]